Please note: The information displayed on this page might be outdated.
Arcus Biosciences: Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies. Arcus has several programs targeting important immuno-oncology pathways, including a dual adenosine receptor antagonist AB928, which is in a Phase 1/1b program to evaluate AB928 in combination with other agents in multiple tumor types, and an anti-PD-1 antibody AB122, which is being evaluated in a Phase 1 trial and is being tested in combination with Arcus’s other product candidates. Arcus’s other programs include AB154, an anti-TIGIT antibody, which is in a Phase 1 trial to evaluate AB154 as monotherapy and in combination with AB122, and AB680, a small molecule inhibitor of CD73, which has entered clinical development. Arcus has extensive in-house expertise in medicinal chemistry, immunology, biochemistry, pharmacology and structural biology.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Disease Space
Immuno-Oncology, Oncology
Listing
Public, USA
Market Cap
1B +
Website:
Address:
3928 Point Eden Way
Hayward, CA 94545
United States

Company Participants at Class of 2018 Biotech IPO Investor Day

  • Terry Rosen, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Arcus Biosciences, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
7.72 3,540,850 86.86 13F 2020-03-31
Boxer Capital LLC 6.73 3,084,883 75.67 13F 2020-03-31
Tavistock Life Sciences Co. (Investment Management) 6.59 3,022,391 74.14 Stakes 2020-02-03
The Vanguard Group, Inc. 5.04 2,309,369 56.65 Funds 2020-05-31
Invus Financial Advisors LLC 4.02 1,842,077 45.19 13F 2020-03-31
Vanguard Group, Inc. (Subfiler) 3.22 1,474,181 36.16 13F 2020-03-31
BlackRock Fund Advisors 2.64 1,210,079 29.68 13F 2020-03-31
BlackRock Institutional Trust Co. NA 2.43 1,112,646 27.29 13F 2020-03-31
Partner Fund Management LP 1.77 809,511 19.86 13F 2020-03-31
Hillhouse Capital Advisors Ltd. (Cayman Islands) 1.67 767,128 18.82 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.